These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 656149)

  • 21. Effect of sympathomimetic amines on the synaptosomal transport of noradrenaline, dopamine and 5-hydroxytryptamine.
    Raiteri M; Del Carmine R; Bertollini A; Levi G
    Eur J Pharmacol; 1977 Jan; 41(2):133-43. PubMed ID: 832672
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The effect of amantadine on radiolabeled biogenic amines in the rat brain.
    Symchowicz S; Korduba CA; Veals J
    Eur J Pharmacol; 1973 Feb; 21(2):155-60. PubMed ID: 4696098
    [No Abstract]   [Full Text] [Related]  

  • 23. Dopamine uptake in striatal and hypothalamic synaptosomes: conformational selectivity of the inhibition.
    Tuomisto L; Tuomisto J; Smissman EE
    Eur J Pharmacol; 1974 Mar; 25(3):351-61. PubMed ID: 4827861
    [No Abstract]   [Full Text] [Related]  

  • 24. Mechanisms of transport for the uptake and release of biogenic amines in nerve endings.
    Bogdanski DF
    Adv Exp Med Biol; 1976; 69():291-305. PubMed ID: 133592
    [No Abstract]   [Full Text] [Related]  

  • 25. Blockade by newly-developed antidepressants of biogenic amine uptake into rat brain synaptosomes.
    Bolden-Watson C; Richelson E
    Life Sci; 1993; 52(12):1023-9. PubMed ID: 8445992
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Inhibition of amine uptake by 4-phenyl-bicyclo(2,2,2)octan-1-amine hydrochloride monohydrate (EXP 561) in rats.
    Fuller RW; Snoddy HD; Perry KW
    Biochem Pharmacol; 1976 Nov; 25(21):2409-10. PubMed ID: 999731
    [No Abstract]   [Full Text] [Related]  

  • 27. Mepiprazole, a new psychotropic drug: effects on uptake and retention of monoamines in rat brain synaptosomes.
    Placheta P; Singer E; Kriwanek W; Hertting G
    Psychopharmacology (Berl); 1976 Aug; 48(3):295-301. PubMed ID: 9660
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Inhibition of biogenic amines uptake by imipramine, desipramine, 2 OH-imipramine and 2 OH-desipramine in rat brain.
    Javaid JI; Perel JM; Davis JM
    Life Sci; 1979 Jan; 24(1):21-8. PubMed ID: 763066
    [No Abstract]   [Full Text] [Related]  

  • 29. Inhibition of the uptake of 5-hydroxytryptamine, noradrenaline and dopamine into rat brain homogenates by various hydroxylated tryptamines.
    Horn AS; Baumgarten HG; Schlosserberger HG
    J Neurochem; 1973 Jul; 21(1):233-6. PubMed ID: 4720899
    [No Abstract]   [Full Text] [Related]  

  • 30. Panuramine, a selective inhibitor of uptake of 5-hydroxytryptamine in the brain of the rat.
    Blurton PA; Broadhurst AM; Cross JA; Ennis C; Wood MD; Wyllie MG
    Neuropharmacology; 1984 Sep; 23(9):1049-52. PubMed ID: 6514142
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Neurochemical characterization of a new potent and selective serotonin uptake inhibitor: Lu 10-171.
    Hyttel J
    Psychopharmacology (Berl); 1977 Mar; 51(3):225-33. PubMed ID: 403537
    [TBL] [Abstract][Full Text] [Related]  

  • 32. In vivo effects of LR5182, cis-3-(3,4-dichlorophenyl)-2-n,n-dimethylaminomethyl- bicyclo-[2,2,2]-octane hydrochloride, an inhibitor of uptake into dopamine and norepinephrine neurons.
    Fuller RW; Perry KW; Snoddy HD
    Neuropharmacology; 1979 May; 18(5):497-501. PubMed ID: 460546
    [No Abstract]   [Full Text] [Related]  

  • 33. Effects of pre- and post-treatment with EXP 561 on the amine-depleting effects of p-chloroamphetamine and 6-hydroxydopamine in rats.
    Fuller RW; Snoddy HD
    Res Commun Chem Pathol Pharmacol; 1978 Sep; 21(3):457-65. PubMed ID: 705024
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Selective inhibition of noradrenaline and serotonin uptake by C 49802-B-Ba and CGP 6085 A.
    Waldmeier PC; Baumann PA; Wilhelm M; Bernasconi R; Maître L
    Eur J Pharmacol; 1977 Dec; 46(4):387-91. PubMed ID: 590347
    [TBL] [Abstract][Full Text] [Related]  

  • 35. d-Amphetamine as a releaser or reuptake inhibitor of biogenic amines in synaptosomes.
    Raiteri M; Bertollini A; Angelini F; Levi G
    Eur J Pharmacol; 1975 Nov; 34(1):189-95. PubMed ID: 1234761
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Specificity of release of biogenic amines from isolated rat brain tissue as a function of the meta substituent of N-ethylamphetamine derivatives.
    Tessel RE; Rutledge CO
    J Pharmacol Exp Ther; 1976 May; 197(2):253-62. PubMed ID: 1271279
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of mazindol on rat brain synaptosomal monoamine uptake.
    Sugrue MF; Mireylees SE
    Biochem Pharmacol; 1978; 27(14):1843-7. PubMed ID: 708465
    [No Abstract]   [Full Text] [Related]  

  • 38. Ageing and dopamine uptake by subcellular fractions of the C57BL/6J male mouse brain.
    Jonec V; Finch CE
    Brain Res; 1975 Jun; 91(2):197-215. PubMed ID: 1164671
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of meclofenoxate on the level and turnover of biogenic monoamines in the rat brain.
    Petkov VV; Grahovska T; Petkov VD; Konstantinova E
    Arzneimittelforschung; 1985; 35(12):1778-81. PubMed ID: 2420335
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Inhibition of in vitro amine uptake into rat brain synaptosomes after in vivo administration of antidepressants.
    Manias B; Taylor DA
    Eur J Pharmacol; 1983 Nov; 95(3-4):305-9. PubMed ID: 6653676
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.